GlassScriptPhysician profile
Jackey D Turner
NPI 1205899267
$7,341.94
in general payments reported to CMS, 2019-2025
45 companies · $552 in 2025
The $552 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $741 · 2021: $1,441 · 2022: $1,793 · 2023: $1,000 · 2024: $913 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,464.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,139.82 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Novo Nordisk INC | $665.20 | 2019-2025 | Ozempic, Saxenda, Rybelsus |
| Amgen INC. | $641.99 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $521.21 | 2019-2025 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $404.70 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $339.76 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $321.85 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $286.98 | 2019-2023 | Trulance, Xifaxan |
| Abbott Laboratories | $225.05 | 2021-2024 | Freestyle Libre, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $223.93 | 2019-2022 | |
| Amarin Pharma, INC. | $219.29 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $216.23 | 2020-2023 | |
| Teva Pharmaceuticals USA, INC. | $178.99 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $170.39 | 2022 | |
| Sanofi-Aventis U.S. LLC | $168.17 | 2019-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackey Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.